Petredis Investment Advisors LLC Has $1.38 Million Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Petredis Investment Advisors LLC lessened its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,649 shares of the company’s stock after selling 329 shares during the quarter. Petredis Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,380,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of the company. Mesirow Financial Investment Management Inc. lifted its position in GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after buying an additional 1,159 shares in the last quarter. LMR Partners LLP acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $7,387,000. Principal Financial Group Inc. boosted its holdings in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock valued at $94,780,000 after buying an additional 19,010 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of GE HealthCare Technologies in the third quarter valued at $1,396,000. Finally, Everence Capital Management Inc. increased its holdings in GE HealthCare Technologies by 118.2% during the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company’s stock worth $1,475,000 after buying an additional 10,220 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by insiders.

GE HealthCare Technologies Stock Up 0.6 %

Shares of NASDAQ GEHC opened at $88.67 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $71.42 and a 52 week high of $94.55. The stock’s fifty day moving average is $82.32 and its 200 day moving average is $84.69. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The stock has a market capitalization of $40.51 billion, a P/E ratio of 24.36, a PEG ratio of 2.88 and a beta of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.99 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.85%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GEHC. Wells Fargo & Company boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Stifel Nicolaus lifted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research report on Monday, September 30th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. One analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.